heart
-
Bayer, Dr Reddy’s in marketing, distribution agreement for second brand of Vericiguat in India
Vericiguat is a soluble guanylate cyclase (sGC) stimulator, in India, is indicated, along with guideline-based medical therapy, in adults with…
Read More » -
Lupin launches patient support prog on cardiovascular disease
Jeet can be accessible through the Play or App Store, as well as the website https://lupinjeet.com Lupin announced the launch…
Read More » -
Lupin Digital Health, The American College of Cardiology collaborates
To revolutionise in-home cardiovascular care in India with digital therapeutics Lupin Digital Health, India’s first evidence-based cardiology digital therapeutics (DTx)…
Read More » -
Global Hospital, Parel unveils robot-assisted heart surgery prog
This ground-breaking programme marks a major advance in medical technology and offers patients a state-of-the-art heart surgery experience Global Hospital,…
Read More » -
Aarthi Scans partners with Siemens Healthineers
Introduces innovative AI screening to assess heart attack risk Aarthi Scans & Labs, a pan-India integrated diagnostic chain, is proud…
Read More » -
Marengo Asia Hospitals partners with Werfen for transfusion-free heart transplants
The Marengo Asia-Werfen partnership will play a crucial role in the development of ‘Centre of Excellence’ A very first-of-its-kind in…
Read More » -
MSN Group launches Sacutan tabs to treat heart disease
A bioequivalent generic, Sacutan tablets (Sacubitril/Valsartan) is indicated to reduce the risk of cardiovascular death and hospitalisation for heart failure in patients with chronic…
Read More » -
Lupin launches heart failure combination drug Sacubitril and Valsartan
Valentas and Arnipin tablets are available in 200 mg, 100 mg, and 50 mg Lupin has launched combination drug Sacubitril…
Read More » -
Experts at Manipal Hospitals Sarjapur discuss benefits of TAVI or TAVR procedure
The procedure is beneficial for critical heart valve-related conditions During a recently held press conference organised by Manipal Hospital Sarjapur,…
Read More » -
Boehringer Ingelheim’s Jardiance bags CDSCO approval
The drug is the first treatment for heart failure with preserved ejection fraction (HFpEF) in India Boehringer Ingelheim has received…
Read More »